Nebivolol (5.0mg) .. .. . . .

NEBIVALVE 5.0 
Nebivolol (5.0mg)
NEBIVALVE is a medication that belongs to the class of drugs known as beta-blockers, which are used primarily to manage hypertension (high blood pressure) and to help prevent heart attacks and strokes. Unlike traditional beta-blockers, Nebivolol has a unique dual mechanism of action: it selectively blocks beta-1 adrenergic receptors in the heart to reduce heart rate and blood pressure, and it also promotes vasodilation (widening of blood vessels) through its action on nitric oxide release. This dual action makes Nebivolol particularly useful for reducing cardiovascular risk while minimizing some of the common side effects associated with non-selective beta-blockers.
Mechanism of Action
NEBIVALVE primary mechanism is its selective inhibition of beta-1 adrenergic receptors in the heart, which decreases the heart rate and the force of the heart's contractions, leading to a reduction in blood pressure. Additionally, Nebivolol differs from other beta-blockers in its ability to increase nitric oxide availability, contributing to vasodilation and further lowering of blood pressure.
Indications
Hypertension: NEBIVALVE is indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents.
Heart Failure: While not universally approved for this indication, some regions recognize Nebivolol's benefits in managing heart failure, particularly in older adults, due to its vasodilatory effects and favorable impact on endothelial function.
Dosage and Administration
The starting dose and the maintenance dose of NEBIVALVE for hypertension treatment can vary depending on the patient's response and tolerability. It is typically administered once daily, with or without food. Dosage adjustments may be necessary based on clinical response and any concurrent medical conditions.
Side Effects
Common side effects of NEBIVALVE may include:
Headache
Fatigue
Dizziness
Nausea
Diarrhea
Less common but more serious side effects can include bradycardia (slow heart rate), hypotension (low blood pressure), and respiratory issues in patients with asthma or chronic obstructive pulmonary disease (COPD).Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
 For further information please contact:
 info@sterispharma.com  / contact@sterispharma.com 
call/whatsapp: 8209542042, 8955945010,7877551268, 6377716668, 
order now:https://www.sterisonline.com/product/nebivalve-5-0-30-s-133333